Cargando…

Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome

BACKGROUND: Marfan syndrome (MFS) is a dominant monogenic disorder caused by mutations in fibrillin 1 (FBN1). Rarely, compound heterozygosity for FBN1 mutations has been described. METHODS: A large kindred with MFS was assessed clinically over decades, and genetically using exome and/or Sanger seque...

Descripción completa

Detalles Bibliográficos
Autores principales: McInerney‐Leo, Aideen M., West, Jennifer, Wheeler, Lawrie, Leo, Paul J., Summers, Kim M., Anderson, Lisa, Brown, Matthew A., West, Malcolm, Duncan, Emma L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057098/
https://www.ncbi.nlm.nih.gov/pubmed/31950671
http://dx.doi.org/10.1002/mgg3.1116
_version_ 1783503591859814400
author McInerney‐Leo, Aideen M.
West, Jennifer
Wheeler, Lawrie
Leo, Paul J.
Summers, Kim M.
Anderson, Lisa
Brown, Matthew A.
West, Malcolm
Duncan, Emma L.
author_facet McInerney‐Leo, Aideen M.
West, Jennifer
Wheeler, Lawrie
Leo, Paul J.
Summers, Kim M.
Anderson, Lisa
Brown, Matthew A.
West, Malcolm
Duncan, Emma L.
author_sort McInerney‐Leo, Aideen M.
collection PubMed
description BACKGROUND: Marfan syndrome (MFS) is a dominant monogenic disorder caused by mutations in fibrillin 1 (FBN1). Rarely, compound heterozygosity for FBN1 mutations has been described. METHODS: A large kindred with MFS was assessed clinically over decades, and genetically using exome and/or Sanger sequencing. RESULTS: A previously identified FBN1 missense variant (p.Tyr754Cys) was confirmed in all subjects with MFS. An additional variant (p.Met2273Thr), previously associated with incomplete MFS, was identified in three siblings. These three compound heterozygous individuals had aortic dilatation at early age (all <30 years): one also had cerebral and ocular aneurysms; and one, who had undergone surgical repair aged 18 years, died from aortic dissection at 31 years. In contrast, their heterozygous father (p.Tyr754Cys) with MFS died at 57 years (myocardial infarction) without requiring surgical intervention and one heterozygous (p.Tyr754Cys) sibling has aortic dilatation presenting >40 years but not requiring surgical intervention. Another heterozygous (p.Tyr754Cys) sibling did require aortic root repair (28 years). The heterozygous (p.Met2273Thr) mother had aortic dilatation diagnosed at age 68 years but has not required surgical repair. CONCLUSION: Although compound heterozygosity or homozygosity is rare in MFS, it should be considered when there is an unusually severe phenotype in a subset of family members.
format Online
Article
Text
id pubmed-7057098
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70570982020-03-12 Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome McInerney‐Leo, Aideen M. West, Jennifer Wheeler, Lawrie Leo, Paul J. Summers, Kim M. Anderson, Lisa Brown, Matthew A. West, Malcolm Duncan, Emma L. Mol Genet Genomic Med Clinical Reports BACKGROUND: Marfan syndrome (MFS) is a dominant monogenic disorder caused by mutations in fibrillin 1 (FBN1). Rarely, compound heterozygosity for FBN1 mutations has been described. METHODS: A large kindred with MFS was assessed clinically over decades, and genetically using exome and/or Sanger sequencing. RESULTS: A previously identified FBN1 missense variant (p.Tyr754Cys) was confirmed in all subjects with MFS. An additional variant (p.Met2273Thr), previously associated with incomplete MFS, was identified in three siblings. These three compound heterozygous individuals had aortic dilatation at early age (all <30 years): one also had cerebral and ocular aneurysms; and one, who had undergone surgical repair aged 18 years, died from aortic dissection at 31 years. In contrast, their heterozygous father (p.Tyr754Cys) with MFS died at 57 years (myocardial infarction) without requiring surgical intervention and one heterozygous (p.Tyr754Cys) sibling has aortic dilatation presenting >40 years but not requiring surgical intervention. Another heterozygous (p.Tyr754Cys) sibling did require aortic root repair (28 years). The heterozygous (p.Met2273Thr) mother had aortic dilatation diagnosed at age 68 years but has not required surgical repair. CONCLUSION: Although compound heterozygosity or homozygosity is rare in MFS, it should be considered when there is an unusually severe phenotype in a subset of family members. John Wiley and Sons Inc. 2020-01-16 /pmc/articles/PMC7057098/ /pubmed/31950671 http://dx.doi.org/10.1002/mgg3.1116 Text en © 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Reports
McInerney‐Leo, Aideen M.
West, Jennifer
Wheeler, Lawrie
Leo, Paul J.
Summers, Kim M.
Anderson, Lisa
Brown, Matthew A.
West, Malcolm
Duncan, Emma L.
Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome
title Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome
title_full Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome
title_fullStr Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome
title_full_unstemmed Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome
title_short Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome
title_sort compound heterozygous mutations in fbn1 in a large family with marfan syndrome
topic Clinical Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057098/
https://www.ncbi.nlm.nih.gov/pubmed/31950671
http://dx.doi.org/10.1002/mgg3.1116
work_keys_str_mv AT mcinerneyleoaideenm compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome
AT westjennifer compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome
AT wheelerlawrie compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome
AT leopaulj compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome
AT summerskimm compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome
AT andersonlisa compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome
AT brownmatthewa compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome
AT westmalcolm compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome
AT duncanemmal compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome